All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
• Eisai Inc., of Woodcliff Lake, N.J., said the FDA granted orphan drug designation to E7777 for cutaneous T-cell lymphoma. E7777 is designed to have an improved purity profile and manufacturing process.
